This company has been marked as potentially delisted and may not be actively trading. Can B (CANB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesTrendsBuy This Stock CANB vs. COSM, HWH, MEDS, BIMI, MCK, COR, CAH, HLF, NUS, and BCTXShould you be buying Can B stock or one of its competitors? The main competitors of Can B include Cosmos Health (COSM), HWH International (HWH), TRxADE HEALTH (MEDS), BIMI (BIMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Herbalife (HLF), Nu Skin Enterprises (NUS), and BriaCell Therapeutics (BCTX). Can B vs. Cosmos Health HWH International TRxADE HEALTH BIMI McKesson Cencora Cardinal Health Herbalife Nu Skin Enterprises BriaCell Therapeutics Cosmos Health (NASDAQ:COSM) and Can B (NASDAQ:CANB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, community ranking, earnings, profitability, valuation and analyst recommendations. Does the MarketBeat Community prefer COSM or CANB? Cosmos Health received 24 more outperform votes than Can B when rated by MarketBeat users. Likewise, 70.69% of users gave Cosmos Health an outperform vote while only 58.62% of users gave Can B an outperform vote. CompanyUnderperformOutperformCosmos HealthOutperform Votes4170.69% Underperform Votes1729.31% Can BOutperform Votes1758.62% Underperform Votes1241.38% Does the media favor COSM or CANB? In the previous week, Cosmos Health had 3 more articles in the media than Can B. MarketBeat recorded 3 mentions for Cosmos Health and 0 mentions for Can B. Cosmos Health's average media sentiment score of 0.47 beat Can B's score of -0.14 indicating that Cosmos Health is being referred to more favorably in the media. Company Overall Sentiment Cosmos Health Neutral Can B Neutral Is COSM or CANB more profitable? Cosmos Health has a net margin of -36.39% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat Cosmos Health's return on equity.Company Net Margins Return on Equity Return on Assets Cosmos Health-36.39% -9.39% -5.10% Can B -1,238.33%N/A -218.65% Which has stronger valuation & earnings, COSM or CANB? Can B has lower revenue, but higher earnings than Cosmos Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCosmos Health$54.43M0.22-$18.54M-$1.16-0.38Can B$2.16M1.19-$9.74MN/AN/A Do institutionals & insiders have more ownership in COSM or CANB? 12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 6.1% of Can B shares are owned by institutional investors. 15.6% of Cosmos Health shares are owned by company insiders. Comparatively, 11.4% of Can B shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, COSM or CANB? Cosmos Health has a beta of 5.5, suggesting that its share price is 450% more volatile than the S&P 500. Comparatively, Can B has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500. SummaryCosmos Health beats Can B on 10 of the 13 factors compared between the two stocks. Get Can B News Delivered to You Automatically Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CANB vs. The Competition Export to ExcelMetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.56M$24.04B$5.27B$8.46BDividend YieldN/A1.34%4.95%4.15%P/E RatioN/A13.7426.5619.69Price / Sales1.1910.64400.60120.60Price / CashN/A12.9538.2534.62Price / Book-0.1132.446.684.52Net Income-$9.74M$872.92M$3.22B$248.10M Can B Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CANBCan BN/A$0.03+1.3%N/A+17.2%$2.56M$2.16M0.0016COSMCosmos Health2.0146 of 5 stars$0.44-4.3%N/A-39.3%$11.95M$54.43M-0.18100Earnings ReportHWHHWH InternationalN/A$1.14+3.1%N/A-78.1%$7.35M$1.25M0.00N/AEarnings ReportPositive NewsGap UpMEDSTRxADE HEALTHN/A$0.95-0.9%N/A-83.9%$1.34M$7.45M0.0050Gap DownBIMIBIMIN/A$0.00+412.5%N/A-100.0%$48,000.00$12.63M0.00520Gap DownHigh Trading VolumeMCKMcKesson4.4217 of 5 stars$711.23+0.6%$681.00-4.3%+28.0%$89.14B$344.58B32.5775,000Analyst UpgradePositive NewsCORCencora4.6487 of 5 stars$291.12-0.3%$290.00-0.4%+28.7%$56.45B$638.56M41.4142,000Positive NewsCAHCardinal Health4.7167 of 5 stars$151.80-0.1%$146.43-3.5%+56.2%$36.67B$222.28B28.3246,500Positive NewsHLFHerbalife4.5876 of 5 stars$6.86-5.8%$11.50+67.8%-36.9%$698.16M$4.95B2.7510,100NUSNu Skin Enterprises3.1924 of 5 stars$5.80-2.1%$6.88+18.6%-45.0%$288.15M$1.73B-1.9613,400Dividend AnnouncementNews CoveragePositive NewsGap UpBCTXBriaCell Therapeutics2.1748 of 5 stars$3.42-11.4%$32.00+835.7%-88.4%$12.69MN/A-0.268Positive News Related Companies and Tools Related Companies COSM Competitors HWH Competitors MEDS Competitors BIMI Competitors MCK Competitors COR Competitors CAH Competitors HLF Competitors NUS Competitors BCTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CANB) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored“Market Wizard” signals rare opportunityThe Fed Is Losing Control — What Comes Next Will Shock Traders The Fed is stuck — rising inflation and risi...Brownstone Research | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredThe Silver Squeeze Is Already Here—Are You Ready?A Silver Supply Crunch + Rising Demand = A Perfect Storm. Here's What You Need To KnowPriority Gold | SponsoredTrump’s Secret WeaponWall Street is nervous. Billionaires are shifting assets. And everyday investors? Most are completely unprepa...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CANB Stock Free CANB Stock Alerts